Publications
118
Citations
6,944
Est. group size
—
Recurring co-author estimate
Active years
41
Publishing since 1985
Katherine J. Kelly's research spans two main areas of medicine: kidney injury and disease, and the biology of blood cancers such as acute myeloid leukemia. Recent work focuses on how epigenetic changes (chemical modifications that turn genes on or off without altering the DNA sequence itself) drive leukemia, as well as the mechanisms by which kidney damage from restricted blood flow harms other organs in the body. Much of this involves single-cell and genomic techniques to study cellular changes in detail.
Publication activity has grown over the last decade, rising from a few papers per year to a steady output of around 10-13 per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Glucarpidase for treatment of high-dose methotrexate toxicity
Blood · 2025
- DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia
Leukemia · 2025
- GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Mechanisms of Injury and Protection in Remote Organs After Kidney Ischemia
Journal of the American Society of Nephrology · 2025
- Mechanisms of Injury and Protection in Ischemic AKI
Journal of the American Society of Nephrology · 2025
- Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
Nature Communications · 2024
- EpiCHAOS: a metric to quantify epigenomic heterogeneity in single-cell data
Genome biology · 2024
- Genocopy of <i>EVI1</i>-AML with Paraneoplastic Diabetes Insipidus: <i>PRDM16</i> Overexpression By t(1;2) and Enhancer Hijacking
Blood · 2024
- Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including <i>MNX1</i> activation via deletion 7q
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- EpiCHAOS: a metric to quantify epigenomic heterogeneity in single-cell data
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Impact of VA Hematology/Oncology Clinical Pharmacy Practitioners in the Review of Community Prescriptions for Specialty Medications
Federal Practitioner · 2024
- Mechanisms of Injury and Protection in Ischemic AKI
Journal of the American Society of Nephrology · 2024
- Genocopy of <scp> <i>EVI1</i> </scp> ‐ <scp>AML</scp> with paraneoplastic diabetes insipidus: <scp> <i>PRDM16</i> </scp> overexpression by t(1;2)(p36;p21) and enhancer hijacking
British Journal of Haematology · 2024
- Acute Kidney Injury
Elsevier eBooks · 2024
- Impaired microvascular circulation in distant organs following renal ischemia
PLoS ONE · 2023
- Journal of the American Society of Nephrology×15
- bioRxiv (Cold Spring Harbor Laboratory)×10
- American Journal of Kidney Diseases×5
- Kidney International×4
- HemaSphere×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile